Eli Lilly and Co

Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
47,000
Ticker
LLY
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Eli Lilly and Company is a leading pharmaceutical firm with a global reputation for developing and marketing innovative medicines. Founded in 1876 and headquartered in Indianapolis, Indiana, the compa...

Eli Lilly and Co's GHG Emissions Data Preview

In 2024, Eli Lilly and Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Eli Lilly and Co has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Eli Lilly and Co’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eli Lilly and Co’s data sources below and access millions more through our Disclosure Search.

a. Eli Lilly and Co's Webpage captured from company’s website 2024
a. Eli Lilly and Co's Webpage captured from company’s website 2024
b. Eli Lilly and Co's Sustainability Report 2023
b. Eli Lilly and Co's Sustainability Report 2023
c. Eli Lilly and Co's Webpage captured from company’s website 2020
c. Eli Lilly and Co's Webpage captured from company’s website 2020

Insights into Eli Lilly and Co's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Eli Lilly and Co amounted to 450,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Eli Lilly and Co decreased by 14.61%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Eli Lilly and Co's Scope 1 Emissions Over Time

2018201920202021202220232024055 k110 k165 k220 ktCO2e-4%-17%-1%+9%+6%+5%
  • Total Scope 1
  • Year-over-Year Change

What are Eli Lilly and Co's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Eli Lilly and Co were 192,000 metric tons of CO₂ equivalent (tCO₂e). a

Has Eli Lilly and Co reduced its Scope 1 emissions over time?

Since 2018, Eli Lilly and Co's Scope 1 emissions have decreased by 4.48%, reflecting a declining long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2023), Eli Lilly and Co's Scope 1 emissions increased by 5.49%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Eli Lilly and Co's Scope 2 emissions?

In 2024, Eli Lilly and Co reported Scope 2 greenhouse gas (GHG) emissions of 258,000 tCO₂e using the market-based method. a

Has Eli Lilly and Co reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Eli Lilly and Co's Scope 2 emissions (Market-Based) fell by 25.22% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does Eli Lilly and Co use for Scope 2 reporting?

In 2024, Eli Lilly and Co reported its Scope 2 emissions using the market-based method. a

Eli Lilly and Co's Scope 2 Emissions Over Time

20182019202020212022202320240200 k400 k600 k800 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Eli Lilly and Co’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Eli Lilly and Co reported Scope 1 greenhouse gas (GHG) emissions of 192,000 tCO₂e and total revenues of USD 45,043 millions. This translates into an emissions intensity of 4.26 tCO₂e per millions USD. a

Eli Lilly and Co's Scope 1 Emissions Intensity Compared to Peers

2002,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)5002,00010,000100,000500,000Revenues (Millions of USD)IMolina HealthcareYear: 2024Scope 1: 6,890 tCO2eRevenue: $M 40,646Scope 1 Intensity: 0.17 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MBristol-Myers SquibbYear: 2024Scope 1: 206,726 tCO2eRevenue: $M 48,300Scope 1 Intensity: 4.28 tCO2e/$MJohnson & JohnsonYear: 2024Scope 1: 314,690 tCO2eRevenue: $M 88,820Scope 1 Intensity: 3.54 tCO2e/$MHCA HealthcareYear: 2022Scope 1: 755 tCO2eRevenue: $M 60,400Scope 1 Intensity: 0.01 tCO2e/$MWalgreens Boots AllianceYear: 2024Scope 1: 284,000 tCO2eRevenue: $M 147,655Scope 1 Intensity: 1.92 tCO2e/$MGilead SciencesYear: 2024Scope 1: 53,856 tCO2eRevenue: $M 28,754Scope 1 Intensity: 1.87 tCO2e/$MCenteneYear: 2023Scope 1: 9,998 tCO2eRevenue: $M 154,052Scope 1 Intensity: 0.06 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MPfizerYear: 2024Scope 1: 613,218 tCO2eRevenue: $M 63,627Scope 1 Intensity: 9.64 tCO2e/$MAmgenYear: 2024Scope 1: 147,000 tCO2eRevenue: $M 33,424Scope 1 Intensity: 4.40 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MAbbVieYear: 2024Scope 1: 300,072 tCO2eRevenue: $M 56,334Scope 1 Intensity: 5.33 tCO2e/$MMerck & Co IncYear: 2024Scope 1: 721,200 tCO2eRevenue: $M 64,168Scope 1 Intensity: 11.24 tCO2e/$MHumana IncYear: 2024Scope 1: 37,480 tCO2eRevenue: $M 117,751Scope 1 Intensity: 0.32 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2023Scope 1: 5,383 tCO2eRevenue: $M 3,622Scope 1 Intensity: 1.49 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MElevance HealthYear: 2024Scope 1: 14,390 tCO2eRevenue: $M 176,781Scope 1 Intensity: 0.08 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MEli Lilly and CoYear: 2024Scope 1: 192,000 tCO2eRevenue: $M 45,043Scope 1 Intensity: 4.26 tCO2e/$M

How does Eli Lilly and Co's GHG emissions intensity compare to its peers?

In 2024, Eli Lilly and Co reported a Scope 1 emissions intensity of 4.26 tCO₂e per millions USD. Compared to the peer group median of 4.28 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Eli Lilly and Co rank on GHG emissions intensity within its industry?

In 2024, Eli Lilly and Co ranked 12 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Eli Lilly and Co is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Eli Lilly and Co's GHG Emissions Dataset?
Sign Up